Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Grant Shifflett

Orthopaedic Surgery of the Spine Marina Del Rey, CA Medical Doctor

NPI 1932423456 CMS profile 2780747

13160 Mindanao Way, Suite 300, Marina Del Rey, CA 90292

Open in the dashboard

General payments

$111,549

212 records reported · program years 2019–2025

Research payments

$5,000

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$30,637 paid to institutions, not to them · program year 2025

Through program year 2025, Grant Shifflett of Marina Del Rey, CA is reported in the CMS Open Payments database as having received $111,549 across 212 general payments and $5,000 in research payments paid to them. Separately, studies naming them as principal investigator received $30,637 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 78th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $27,533 17
2024 General $6,281 11
2024 Research $5,000 1
2023 General $11,403 33
2022 General $46,332 93
2021 General $9,218 34
2020 General $4,964 9
2019 General $5,819 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Grant Shifflett
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Grant Shifflett were reported at $27,533. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Grant Shifflett Orthopaedic Surgery of the Spine median Middle half National median
2019 $5,819 $2,106 $337–$18,608 $163
2020 $4,964 $1,213 $156–$15,082 $114
2021 $9,218 $1,834 $271–$15,617 $132
2022 $46,332 $2,015 $320–$17,036 $149
2023 $11,403 $1,925 $336–$14,599 $160
2024 $6,281 $2,110 $341–$12,483 $164
2025 $27,533 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimvie Inc. $41,386 76 payments
  2. Kyocera Medical Technologies, Inc. $19,813 7 payments
  3. Centinel Spine, LLC $19,349 17 payments
  4. Zimmer Biomet Holdings, Inc. $7,020 28 payments
  5. TriMed, Inc. $5,000 1 payment
  6. CTL Medical Corporation $4,932 5 payments
  7. Cerapedics, Inc. $2,604 9 payments
  8. Orthofix Medical, Inc. $2,371 12 payments
  9. Osseus Fusion Systems, LLC $2,367 3 payments
  10. Globus Medical, Inc. $1,885 8 payments
  11. Other $4,820 46 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $85,570 37 payments
  2. Travel and Lodging $14,547 60 payments
  3. Food and Beverage $9,682 104 payments
  4. Honoraria $1,500 1 payment
  5. Entertainment $110 3 payments
  6. Gift $75 1 payment
  7. Education $65 6 payments
Products named General payments · program years 2019–2025
  1. Mobi-C $38,734 51 payments
  2. Vital $20,595 33 payments
  3. PRODISC L $18,606 10 payments
  4. TrellOss-C SA $17,850 8 payments
  5. ProLift Expandable Interbody, 12mm x 28mm, Large 15 degree $15,450 6 payments
  6. Vital Deformity, Degen, Hooks $15,450 6 payments
  7. Timberline $3,308 3 payments
  8. I-FACTOR PEPTIDE ENHANCED BONE GRAFT Peptide Enhanced Bone Graft $2,604 9 payments
  9. I-FACTOR PEPTIDE ENHANCED BONE GRAFT Peptide Enhanced Bone Graft $2,604 9 payments
  10. I-FACTOR PEPTIDE ENHANCED BONE GRAFT Peptide Enhanced Bone Graft $2,604 9 payments
  11. Other $19,675 115 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Globus Medical, Inc. $5,000 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

51

Median for Orthopaedic Surgery: 30

Drug cost

$576

Median for Orthopaedic Surgery: $176

Branded share of claims

45.1%

Median for Orthopaedic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 23 $504
Methylprednisolone Generic 11 $63
Meloxicam Generic 17 $9

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,233 Part D prescribers listed as Orthopaedic Surgery; they describe a distribution and say nothing about conduct.

Records

213 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record